AAV VECTOR C2C12 Errance diagnostique Butyrylcholinesterase Patient registry Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Muscle Neuromuscular diseases Becker muscular dystrophy Actionability Duchenne muscular dystrophy COVID-19 Diagnosis Nuclear envelope CMTX Myologie Next generation sequencing LMNA POPDC1 Treatment delay LMNA-related congenital muscular dystrophy A-type lamins Base de données FAIR Congenital muscular dystrophy Cardiomyopathy INPP5K C elegans GNE Muscular dystrophy Biomarker Dystrophie musculaire Cancer biomarkers COL6A1 Maladies rares et orphelines LMNA gene Exome Dilated cardiomyopathy Cancer CRISPR Gene therapy Lamins Muscle biopsy Rare diseases COL1A1 Myopathies BiP Muscle MRI Cardiac conduction system Laminopathy Treatment Rare neuromuscular diseases Therapy Emerin Biological sciences Heart Maladies rares BVES Calcium handling Dystrophine Dynamin 2 Hypermobile EDS Myopathy Alternative splicing Lamin A/C Allele-specific silencing therapy Myotubes RNA interference Mutations Heart failure Adult SMA Joint laxity Allele‐specific silencing therapy Emery-Dreifuss muscular dystrophy Autophagosome maturation Ehlers‐Danlos Syndrome Clinical trial LGMD Lamin A/C LMNA gene Myogenesis Laminopathie AAV Angiotensin-converting enzyme inhibitors Centronuclear myopathy Titin COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Actionable gene Muscular dystrophy MD Angiotensin-converting enzyme inhibitor Connective tissue Acetyltransferase CSF protein A-type lamin IPSC Allele-specific silencing Lamin A/C nuclei Laminopathies Regeneration Mouse Cardiology Skeletal muscle